The Current Ratio as of December 2024 (TTM) for Karuna Therapeutics, Inc. (KRTX) is 19.31

According to Karuna Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 19.31. This represents a change of -46.57% compared to the average of 36.14 of the last 4 quarters.

Karuna Therapeutics, Inc. (KRTX) Historical Current Ratio (quarterly & annually)

How has KRTX Current Ratio performed in the past?

The mean historical Current Ratio of Karuna Therapeutics, Inc. over the last ten years is 53.77. The current 19.31 Current Ratio has changed 3.49% with respect to the historical average. Over the past ten years (40 quarters), KRTX's Current Ratio was at its highest in in the March 2020 quarter at 145.80. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Karuna Therapeutics, Inc. (KRTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Karuna Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Karuna Therapeutics, Inc. (KRTX) Average Current Ratio

How has KRTX Current Ratio performed in the past?

The current Current Ratio of Karuna Therapeutics, Inc. (KRTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Karuna Therapeutics, Inc. (KRTX) Current Ratio vs. Peers

How is KRTX’s Current Ratio compared to its peers?

Karuna Therapeutics, Inc.’s Current Ratio is greater than IVERIC bio, Inc. (18.63), greater than Blueprint Medicines Corporation (3.32), greater than Amylyx Pharmaceuticals, Inc. (4.55), greater than Day One Biopharmaceuticals, Inc. (14.62), greater than X4 Pharmaceuticals, Inc. (4.89), greater than Inozyme Pharma, Inc. (7.68), greater than Acumen Pharmaceuticals, Inc. (10.43), greater than Mereo BioPharma Group plc (6.10), less than Terns Pharmaceuticals, Inc. (32.99), greater than Mirati Therapeutics, Inc. (7.54), greater than Apellis Pharmaceuticals, Inc. (4.36), greater than Cytokinetics, Incorporated (9.28), less than DICE Therapeutics, Inc. (38.14), less than Edgewise Therapeutics, Inc. (26.35), greater than Dyne Therapeutics, Inc. (17.02),

Build a custom stock screener for Karuna Therapeutics, Inc. (KRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Karuna Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Karuna Therapeutics, Inc. (KRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Karuna Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.